STONEPINE CAPITAL MANAGEMENT, LLC – Xeris Biopharma Holdings, Inc. Transaction History
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$20.16M
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+1.30%
quarter
Xeris Biopharma Holdings, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.00% | 1.28M shares | 2.23M | $1.56 | 12.92M |
| Q2 2022 | share | Increase | +46.99% | 3.72M shares | -2.34M | $1.54 | 11.64M |
| Q1 2022 | share | Increase | +40.09% | 2.26M shares | 3.71M | $2.56 | 7.92M |
| Q4 2021 | share | Increase | 0.00% | 5.65M shares | 16.57M | $2.43 | 5.65M |